Key Takeaways
- Viagra (sildenafil) and Cialis (tadalafil) are FDA-approved for erectile dysfunction (ED). They increase blood flow to the penis during sexual stimulation and do not increase sexual desire.
- PT-141 (bremelanotide) acts on melanocortin receptors in the brain. Its only FDA-approved form is Vyleesi, an injection for low desire in premenopausal women; it is not indicated for men.
- Male PT-141 evidence comes from small 2004 and 2005 studies of nasal and injected research formulations, measured in a lab.
- PT-141 is studied as a desire medication in women. In men, studies measured erections rather than desire, so a clinician decides whether it fits.
- Compounded PT-141 is not FDA-approved, is prescribed off-label, and comes in needle-free troches, nasal spray, strips, and PT-141 + oxytocin tablets.
PT-141 acts on brain receptors linked to desire and isn't FDA-approved for men, while Viagra and Cialis improve erections through blood flow.
If erections are the problem and desire is intact, the evidence points to a PDE5 inhibitor. PT-141 has been studied for desire only in women. In men, the research measured erections, so whether prescription PT-141 formats fit is a decision for a licensed clinician.
PT-141 vs Viagra for erectile dysfunction
The two medications target different steps of sexual response. This table compares what each was studied for.
| Factor | Viagra (sildenafil) and Cialis (tadalafil) | PT-141 (bremelanotide) |
|---|---|---|
| Main target | Blood flow to the penis during sexual stimulation | Melanocortin receptors in the brain |
| Effect on desire | Does not increase sexual desire | Studied for low desire in premenopausal women only; not tested for desire in men |
| FDA status for men | Approved for ED | Not indicated for men; compounded forms are prescribed off-label |
| Evidence in men | FDA-approved for ED; the AUA guideline strongly recommends informing men with ED about oral PDE5 inhibitors | Small 2004 and 2005 lab studies with research formulations |
| Needs sexual stimulation | Yes; it supports the erection response but doesn't start it | Acts on central desire and arousal signaling |
| Formats | Oral tablets | Compounded troches, nasal spray, strips, and PT-141 + oxytocin tablets |
For classic ED with intact interest, PDE5 inhibitors have the deeper human record. No study has tested PT-141 for low desire in men, so using it for that is a clinician's judgment call, not a default.
How Viagra and Cialis work
Both Viagra (sildenafil) and Cialis (tadalafil) belong to a class of medications called PDE5 inhibitors. They improve erections by increasing blood flow to the penis during sexual stimulation, so they need arousal to work, and neither increases sexual desire.
- Sildenafil: the shorter-acting of the two.
- Tadalafil: longer-acting than sildenafil.
- Common side effects: headache, flushing, nasal congestion, heartburn, and changes in color vision with sildenafil; back and muscle pain are also listed for tadalafil.
- The key safety rule: nitrates for chest pain rule out both drugs because of dangerous blood pressure drops.
How PT-141 acts on brain pathways
PT-141 (bremelanotide) works through an entirely different mechanism than PDE5 inhibitors. It activates melanocortin receptors. The FDA label names MC1R and MC4R as the most relevant: MC4R neurons are present in many areas of the central nervous system, while MC1R sits on skin pigment cells, where binding increases pigmentation. FDA states the mechanism by which it improves desire in women is unknown.
The approved product, Vyleesi, is an injection for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Its label says it is not indicated for men or to enhance sexual performance. For men, compounded PT-141 is prescribed off-label.
What the PT-141 studies in men measured
All male PT-141 research is small, early, and measured erections with a RigiScan device in a lab, not desire in daily life:
- Nasal spray, 2004: in healthy men and in men with mild to moderate ED who responded to Viagra, erectile responses were significant versus placebo at the higher research doses tested.
- Injection, 2004: in healthy men, erectile responses were significant versus placebo at the higher research doses tested. In men whose erections were inadequate on Viagra, responses were significant at both doses tested.
- Combination, 2005: in 19 men with ED who responded to Viagra or Levitra, nasal PT-141 plus sildenafil produced a greater erectile response than sildenafil alone, with no new side effects.
None of these studies tested a compounded troche, strip, or tablet, and none measured male libido over time. With those formats, your clinician tracks how you respond.
Is PT-141 better than Viagra?
They answer different questions. Viagra and Cialis are FDA-approved for unreliable erections. PT-141 is studied as a desire medication in women; in men, studies measured erections rather than desire, so a clinician decides whether it fits.
- A PDE5 inhibitor is the approved, well-studied option when interest is intact, and firmness or staying hard is the issue. The AUA strongly recommends informing men with ED about it.
- If interest has faded, or a PDE5 inhibitor works mechanically but sex still feels flat, raise that with a clinician. PT-141 may come up, but no study has tested it for low desire in men.
- Check the causes first, including sleep, mood, and medications. The AUA advises measuring morning testosterone in men with ED and counseling that ED is a risk marker for cardiovascular disease. If testosterone is the issue, oral enclomiphene supports the body's own production; compounded enclomiphene is not FDA-approved and is prescribed off-label.
Combining PT-141 with PDE5 inhibitors
The two work through different pathways, and one small lab study has tested them together.
Can you take PT-141 with Viagra?
Only under a clinician's direction. The only study of the combination is the small 2005 lab study described above. Your clinician decides whether combining them makes sense for you.
Can you take PT-141 with Cialis?
No published study has tested PT-141 with tadalafil. Tadalafil is longer-acting, and bremelanotide raises blood pressure and lowers heart rate for up to 12 hours, so a clinician should review your heart history and medications first.
What a clinician checks before combining
- Blood pressure, heart history, and exercise tolerance.
- Nitrates and alpha-blockers, which interact with PDE5 inhibitors.
- Oral naltrexone, which interacts with bremelanotide.
Alternatives to Viagra to discuss with a clinician
When both firmness and interest have changed, these are the evidence-based options to raise with a clinician:
| Option | What it targets | Evidence and status |
|---|---|---|
| Tadalafil (Cialis) | Erections | FDA-approved for ED; longer-acting than sildenafil |
| PT-141 (compounded) | Desire and arousal signaling | Not FDA-approved for men; small male lab studies |
| PT-141 plus a PDE5 inhibitor | Desire and blood flow together | One 2005 study of 19 men with sildenafil; clinician-directed only |
| Testosterone evaluation | Low testosterone driving low desire or ED | AUA advises morning testosterone testing in men with ED |
| Mental health or sex therapy referral | Performance anxiety, relationship factors | AUA moderate recommendation |
| Lifestyle changes | Vascular risk factors behind ED | AUA notes diet and activity may improve erectile function |
PT-141 formats for men
Rebody offers PT-141 in needle-free formats, all compounded and prescribed off-label. The nasal spray vs troche guide compares the two main options.
| Format | Strength and package |
|---|---|
| PT-141 nasal spray | 5 mg/mL in a 3 mL bottle |
| PT-141 troches | 2 mg; 8 per package |
| PT-141 strips | 2 mg; 24 per package |
| PT-141 + oxytocin dissolving tablets | 1 mg + 20 IU or 2 mg + 40 IU; 8 per package |
A licensed U.S. 503A compounding pharmacy prepares each format for your prescription, and your clinician sets your dose and directions. Compounded PT-141 requires a prescription after a licensed clinician's review and is not FDA-approved.
How getting PT-141 compares with getting a Viagra prescription
Both need a prescription, but the path differs because one is an FDA-approved ED drug and the other is a compounded, off-label medication for men.
| Step | Viagra or Cialis | PT-141 |
|---|---|---|
| Who prescribes | Any licensed prescriber who evaluates your ED | A licensed clinician who reviews desire, blood pressure, heart history, and medications |
| Where it's filled | Retail or mail-order pharmacy, brand or generic | A licensed U.S. 503A compounding pharmacy, made for your prescription |
| What's on the label | FDA-approved directions | Dose and directions set by your clinician |
| Insurance | Varies by plan | Generally not covered by insurance |
Side effect and safety comparison
A clinician screens for the main risks of both before prescribing. For PT-141, most reactions in the injection trials were mild or moderate and short-lived.
| Side effect area | Viagra and Cialis | PT-141 (from the Vyleesi injection label) |
|---|---|---|
| Most common | Headache, flushing, nasal congestion, heartburn | Nausea (40%), flushing (20%), headache (11%); nausea most common early in treatment |
| Blood pressure | Can drop, especially with nitrates | Temporary rise, with lower heart rate, usually resolving within 12 hours |
| Other | Color-vision changes; back and muscle pain with tadalafil | Skin darkening in 1% of trial patients |
| Do not use with | Nitrates | Uncontrolled hypertension or known cardiovascular disease |
| Interactions to mention | Alpha-blockers; tell your clinician | May lower oral naltrexone levels; tell your clinician |
The PT-141 rates come from the injection in premenopausal women; rates for compounded formats haven't been established.
Get urgent care for an erection that is painful or lasts longer than 4 hours, chest pain, fainting, or sudden vision or hearing loss, and tell emergency staff about any recent sildenafil or tadalafil.
Choosing between PT-141, Viagra, and Cialis with a clinician
Viagra and Cialis are built for erections; PT-141 works on brain pathways linked to desire. A clinician works out which function changed and whether your heart health allows either.
With Rebody, a licensed clinician reviews your goals, blood pressure, heart history, and medications; a licensed U.S. 503A pharmacy prepares the PT-141 format you're prescribed, and your care team follows up on side effects, strength, and format.
Start an online visit to see whether PT-141 fits your goals.
Frequently Asked Questions (FAQs)
Is PT-141 more effective than Cialis?
They do different jobs. Cialis is FDA-approved for erectile dysfunction and improves blood flow during arousal. PT-141 acts on desire-related receptors in the brain, and its evidence in men comes from small lab studies.
Does Viagra increase sexual desire?
No. Sildenafil improves blood flow to the penis during sexual stimulation and does not increase sexual desire.
Does PT-141 work when Viagra doesn't?
It hasn't been established. One small 2004 lab study of injected PT-141 included men who didn't respond well to Viagra and found significant erectile responses versus placebo. Still, no larger trial has confirmed PT-141 as an alternative for those men.
What if Viagra improves firmness but sex still feels flat?
That pattern points to desire rather than blood flow, and more sildenafil won't create interest. A clinician can look at the likely causes and discuss options, keeping in mind that no study has tested PT-141 for low desire in men.
Which is better for low libido: PT-141 or Cialis?
Neither has been tested for low libido in men. Cialis improves erections without increasing desire. PT-141 is studied as a desire medication in women, while male studies measured erections, so a clinician decides whether it fits.
Does PT-141 raise testosterone?
No. PT-141 acts on melanocortin receptors in the brain. Low testosterone is a separate question that starts with morning blood tests.
This article is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional about your health or before changing treatment. Do not delay medical care because of something you read here.
Keep reading
- Desire and Erection Medications for Men: PT-141, Sildenafil, and Tadalafil
- Male Libido Treatments Beyond Daily Hormones
- PT-141 Formats for Men: Nasal Spray and Troches
Primary sources
- Rosen RC and colleagues. Intranasal PT-141 in healthy men and men with mild-to-moderate ED
- Diamond LE and colleagues. Injected PT-141 in men with erectile dysfunction
- Diamond LE and colleagues. PT-141 combined with sildenafil in men with ED
- American Urological Association. Erectile Dysfunction Guideline
- FDA. Vyleesi prescribing information
- MedlinePlus. Sildenafil
- MedlinePlus. Tadalafil